Emerging Biotechnology Analyst Breidenbach, along with Dr. Debosch of Washington University, discuss new treatment options for recurrent C. difficile infection on an Analyst/Industry conference call to be held on February 1 at 10 am.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MCRB:
- Seres Therapeutics reports inducement grants under Nasdaq listing rule
- Piper Sandler names three top biotechnology picks for 2023
- Seres Therapeutics price target raised to $13 from $9 at Piper Sandler
- Seres Therapeutics to host virtual investor meeting
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue